GO:0033889 N-sulfoglucosamine-3-sulfatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033889 (N-sulfoglucosamine-3-sulfatase activity) is a molecular_function term describing the hydrolysis of 3-sulfate groups from N-sulfo-D-glucosamine 3-O-sulfate units of heparin.
• The enzyme acts on N-substituted glucosamine 3-O-sulfate residues, removing the sulfate ester at the C3 position.
• This activity is part of the broader sulfatase family and is involved in the degradation and remodeling of heparin and heparan sulfate glycosaminoglycans.
• The enzyme was first biochemically characterized from Flavobacterium heparinum, a soil bacterium that can utilize heparin as a carbon source.
• Studying this activity helps researchers understand glycosaminoglycan turnover, bacterial heparin catabolism, and potential roles in host-microbe interactions.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable functional dissection of genes encoding this activity and their pathways.
Description
N-sulfoglucosamine-3-sulfatase activity (GO:0033889) is a molecular function defined as the catalysis of the hydrolysis of the 3-sulfate groups of the N-sulfo-D-glucosamine 3-O-sulfate units of heparin. This activity is critical for the breakdown and modification of heparin and related glycosaminoglycans, which are complex polysaccharides involved in numerous biological processes including anticoagulation, cell signaling, and extracellular matrix organization. The enzyme responsible for this activity was first identified and characterized in Flavobacterium heparinum, a bacterium capable of degrading heparin. Understanding this enzymatic activity is important for researchers studying glycosaminoglycan metabolism, bacterial pathogenesis, and the development of heparin-based therapeutics. The ability to precisely edit genes encoding such enzymes using CRISPR technologies opens new avenues for functional studies and biotechnological applications.
N-sulfoglucosamine-3-sulfatase activity At A Glance
| GO ID | GO:0033889 |
|---|---|
| GO term | N-sulfoglucosamine-3-sulfatase activity |
| Ontology | molecular_function |
| Synonym | chondroitinsulfatase activity; N-sulfo-3-sulfoglucosamine 3-sulfohydrolase activity |
| Major function | Hydrolysis of 3-sulfate groups from N-sulfo-D-glucosamine 3-O-sulfate units of heparin |
| Substrate | N-sulfo-D-glucosamine 3-O-sulfate units in heparin |
| Product | N-sulfo-D-glucosamine units with removal of 3-sulfate |
| Source organism (first characterized) | Flavobacterium heparinum |
What Is GO:0033889?
N-sulfoglucosamine-3-sulfatase activity (GO:0033889) is a molecular function that catalyzes the hydrolysis of the 3-sulfate ester bond in N-sulfo-D-glucosamine 3-O-sulfate residues within heparin. In other words, it removes a sulfate group from the third carbon position of a specific sugar unit found in heparin, a highly sulfated polysaccharide. This reaction is a key step in the enzymatic degradation and remodeling of heparin and heparan sulfate.
Why Is N-sulfoglucosamine-3-sulfatase activity Important in Cell Biology?
N-sulfoglucosamine-3-sulfatase activity is important because it participates in the catabolism of heparin and heparan sulfate, which are key components of the extracellular matrix and cell surfaces. These molecules regulate diverse processes such as blood coagulation, growth factor signaling, and inflammation. The enzyme's ability to remove 3-sulfate groups can alter the biological properties of heparin, including its anticoagulant activity. Studying this activity provides insights into bacterial heparin degradation pathways and may inform the design of heparin-based drugs and glycan engineering strategies.
• Enables the breakdown of heparin, a widely used anticoagulant drug.
• Contributes to the turnover of heparan sulfate, which modulates cell signaling and development.
• Provides a model for understanding sulfatase enzyme mechanisms.
• Relevant to bacterial pathogenesis and host-microbe interactions involving glycosaminoglycans.
• Potential target for biotechnological production of modified heparins.
• Helps elucidate the role of 3-O-sulfation in glycosaminoglycan function.
• Supports research on glycosaminoglycan storage disorders and related diseases.
• Facilitates the development of glycan-based therapeutics and diagnostics.
Molecular Mechanism of N-sulfoglucosamine-3-sulfatase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto the heparin chain at a specific spot.
The enzyme recognizes and binds to N-sulfo-D-glucosamine 3-O-sulfate units within heparin. This binding likely involves electrostatic interactions between the enzyme's active site and the negatively charged sulfate groups and carboxylates of the substrate. The specificity for the 3-O-sulfate position is determined by the three-dimensional structure of the active site pocket.
Catalytic Hydrolysis
In simple terms: The enzyme then cuts the sulfate group off the sugar.
Once bound, the enzyme catalyzes the hydrolysis of the 3-sulfate ester bond. This reaction typically involves a conserved sulfatase mechanism where a formylglycine residue in the active site is hydrated to a gem-diol, which then attacks the sulfate ester, leading to the release of sulfate and the formation of an alcohol at the C3 position of the glucosamine unit.
Product Release and Enzyme Turnover
In simple terms: After cutting, the enzyme lets go of the modified sugar and is ready to act again.
Following hydrolysis, the desulfated product (N-sulfo-D-glucosamine without the 3-sulfate) is released from the active site, allowing the enzyme to bind a new substrate molecule. The enzyme may undergo conformational changes to facilitate product release and reset for another catalytic cycle.
Cofactors and Metal Requirements
In simple terms: Some enzymes need helper molecules or metals to work.
While specific cofactor requirements for this enzyme are not detailed in the provided literature, many sulfatases require a divalent metal ion (e.g., Ca2+ or Mg2+) for activity. However, the Flavobacterium heparinum 3-O-sulphatase was characterized as a sulfatase that likely uses a formylglycine-dependent mechanism without a metal cofactor.
Regulation of Activity
In simple terms: The enzyme's activity can be turned up or down by the cell.
The regulation of N-sulfoglucosamine-3-sulfatase activity is not well understood in the provided literature. In bacteria, expression of heparin-degrading enzymes is often induced by the presence of heparin or related glycosaminoglycans. Post-translational modification of the enzyme, such as formylglycine generation, is essential for catalytic activity and may be a regulatory point.
Key Genes Involved in GO:0033889 N-sulfoglucosamine-3-sulfatase activity
The following genes and proteins are associated with N-sulfoglucosamine-3-sulfatase activity or related glycosaminoglycan metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Flavobacterium heparinum 3-O-sulphatase (unnamed gene) | Encodes the enzyme with N-sulfoglucosamine-3-sulfatase activity | First characterized enzyme for this activity; model for sulfatase mechanism |
| SULF1 | Human sulfatase 1, acts on heparan sulfate | Potential homolog with related activity; studied in cancer and development |
| SULF2 | Human sulfatase 2, acts on heparan sulfate | Potential homolog; implicated in tumor progression |
| GNS | Glucosamine (N-acetyl)-6-sulfatase | Involved in heparan sulfate degradation; mutations cause mucopolysaccharidosis |
| IDS | Iduronate 2-sulfatase | Heparan sulfate degradation; mutations cause Hunter syndrome |
| HGSNAT | Heparan-alpha-glucosaminide N-acetyltransferase | Heparan sulfate degradation; mutations cause Sanfilippo syndrome |
| NAGLU | N-acetyl-alpha-glucosaminidase | Heparan sulfate degradation; mutations cause Sanfilippo syndrome |
| SGSH | N-sulfoglucosamine sulfohydrolase | Removes N-sulfate groups from heparan sulfate; mutations cause Sanfilippo syndrome |
| ARSB | Arylsulfatase B | Degrades dermatan sulfate and chondroitin sulfate |
| GALNS | Galactosamine (N-acetyl)-6-sulfatase | Degrades keratan sulfate and chondroitin sulfate |
| EXT1 | Exostosin glycosyltransferase 1 | Heparan sulfate biosynthesis |
| EXT2 | Exostosin glycosyltransferase 2 | Heparan sulfate biosynthesis |
| HS6ST1 | Heparan sulfate 6-O-sulfotransferase 1 | Adds 6-O-sulfate groups to heparan sulfate |
| HS3ST1 | Heparan sulfate 3-O-sulfotransferase 1 | Adds 3-O-sulfate groups to heparan sulfate; creates binding sites for antithrombin |
| HS3ST3A1 | Heparan sulfate 3-O-sulfotransferase 3A1 | Adds 3-O-sulfate groups; involved in heparan sulfate modification |
| HS3ST3B1 | Heparan sulfate 3-O-sulfotransferase 3B1 | Adds 3-O-sulfate groups; involved in heparan sulfate modification |
| HS3ST5 | Heparan sulfate 3-O-sulfotransferase 5 | Adds 3-O-sulfate groups; involved in heparan sulfate modification |
| HPSE | Heparanase | Cleaves heparan sulfate chains; involved in matrix remodeling and cancer |
How Is N-sulfoglucosamine-3-sulfatase activity Regulated?
The regulation of N-sulfoglucosamine-3-sulfatase activity is not extensively documented in the provided literature. In bacteria such as Flavobacterium heparinum, the expression of heparin-degrading enzymes is likely induced by heparin or related glycosaminoglycans. The enzyme itself requires post-translational modification of a cysteine residue to formylglycine for catalytic activity, which is a common regulatory feature among sulfatases. Further studies are needed to elucidate transcriptional and post-transcriptional regulation.
N-sulfoglucosamine-3-sulfatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SGSH | Mucopolysaccharidosis IIIA (Sanfilippo syndrome) | Knockout mouse, patient-derived fibroblasts |
| IDS | Mucopolysaccharidosis II (Hunter syndrome) | Knockout mouse, iPSC-derived neurons |
| GNS | Mucopolysaccharidosis IIID (Sanfilippo syndrome) | Knockout mouse, cell lines |
| HGSNAT | Mucopolysaccharidosis IIIC (Sanfilippo syndrome) | Knockout mouse, patient cells |
| NAGLU | Mucopolysaccharidosis IIIB (Sanfilippo syndrome) | Knockout mouse, cell lines |
Mucopolysaccharidoses and Glycosaminoglycan Storage Disorders
Deficiencies in enzymes that degrade heparan sulfate, such as N-sulfoglucosamine-3-sulfatase, could lead to the accumulation of partially degraded glycosaminoglycans, similar to what is seen in mucopolysaccharidoses. Although no human disease has been directly linked to this specific activity, related sulfatase deficiencies cause severe lysosomal storage disorders.
Cancer and Heparan Sulfate Remodeling
Heparan sulfate remodeling enzymes, including sulfatases, are often dysregulated in cancer. Changes in sulfation patterns can affect growth factor signaling and tumor progression. While N-sulfoglucosamine-3-sulfatase activity has not been directly implicated, understanding its role could provide insights into glycosaminoglycan-mediated cancer biology.
Bacterial Pathogenesis and Host Interaction
Bacteria like Flavobacterium heparinum use heparin-degrading enzymes to utilize host glycosaminoglycans as nutrients. This activity may contribute to bacterial survival and pathogenesis in certain niches. Studying this enzyme could reveal targets for antibacterial strategies.
From N-sulfoglucosamine-3-sulfatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic mechanism of N-sulfoglucosamine-3-sulfatase? | Recombinant enzyme, site-directed mutagenesis (point mutation) |
| What is the role of this activity in heparin degradation? | Knockout of the gene in Flavobacterium heparinum or heterologous expression |
| How does loss of this activity affect glycosaminoglycan turnover in human cells? | CRISPR knockout in human cell lines (e.g., HEK293, HepG2) |
| Can we engineer the enzyme for improved heparin processing? | Knock-in of mutant variants, directed evolution |
| What are the interacting partners of the enzyme? | Tagged knock-in (e.g., FLAG, GFP) followed by immunoprecipitation |
| How does overexpression affect heparan sulfate sulfation patterns? | Overexpression in mammalian cells, glycan analysis |
How to Study the N-sulfoglucosamine-3-sulfatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Sulfatase activity assay | Enzymatic hydrolysis of 3-sulfate groups | Kinetic characterization, inhibitor testing |
| HPLC disaccharide analysis | Sulfation patterns of heparan sulfate | Assessing enzyme impact on GAG structure |
| CRISPR knockout | Loss of gene function | Studying cellular phenotypes |
| Site-directed mutagenesis | Effect of specific amino acid changes | Mapping catalytic residues |
| Overexpression | Gain of function | Analyzing pathway activation |
| AP-MS | Protein-protein interactions | Identifying binding partners |
| Glycan microarray | Binding specificity to glycans | Screening substrate preferences |
Enzymatic Activity Assays
To measure N-sulfoglucosamine-3-sulfatase activity, researchers can use radiolabeled or fluorogenic substrates derived from heparin. High-performance liquid chromatography (HPLC) or mass spectrometry can detect the release of sulfate or the desulfated product. These assays are essential for characterizing enzyme kinetics and inhibitor screening.
Glycosaminoglycan Analysis
Disaccharide composition analysis of heparan sulfate/heparin by HPLC or capillary electrophoresis can reveal changes in sulfation patterns upon modulation of the enzyme. This method helps assess the impact of the enzyme on glycosaminoglycan structure in cells or tissues.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 can be used to generate knockout, point mutation, knock-in, or overexpression models to study the gene encoding N-sulfoglucosamine-3-sulfatase activity. These models allow functional interrogation of the enzyme in its native or heterologous context.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify proteins interacting with the enzyme. This approach can uncover regulatory subunits or substrate channeling partners, providing insights into the enzyme's cellular roles.
How CRISPR Can Be Used to Study GO:0033889 N-sulfoglucosamine-3-sulfatase activity
Knockout
CRISPR knockout of the gene encoding N-sulfoglucosamine-3-sulfatase activity can abolish enzyme function, allowing researchers to study its role in heparin degradation and glycosaminoglycan turnover. Knockout cell lines or bacteria can be used to assess metabolic and signaling changes.
Point Mutation
Introducing point mutations in the catalytic domain (e.g., the formylglycine-generating sequence) can help identify essential residues for sulfatase activity. This approach provides mechanistic insights into the enzyme's catalytic mechanism.
Knock-in
Knock-in of tagged versions (e.g., FLAG, GFP) of the enzyme allows for localization and interaction studies. Additionally, knock-in of disease-associated or engineered variants can model human conditions or improve enzyme properties.
Overexpression
Overexpression of the enzyme in mammalian or bacterial cells can lead to increased desulfation of heparan sulfate, affecting cell signaling and matrix properties. This model is useful for studying gain-of-function effects and biotechnological applications.
How EDITGENE Supports N-sulfoglucosamine-3-sulfatase activity Research
Researchers studying N-sulfoglucosamine-3-sulfatase activity-related genes often need to determine whether a candidate gene is causally involved in glycosaminoglycan metabolism, bacterial pathogenesis, or related diseases. EDITGENE provides comprehensive CRISPR gene editing services to accelerate such investigations.
Contact EDITGENE today to design your custom CRISPR model for N-sulfoglucosamine-3-sulfatase activity research.
Frequently Asked Questions About N-sulfoglucosamine-3-sulfatase activity
What is N-sulfoglucosamine-3-sulfatase activity?
It is a molecular function (GO:0033889) that catalyzes the hydrolysis of 3-sulfate groups from N-sulfo-D-glucosamine 3-O-sulfate units of heparin.
What genes are involved in N-sulfoglucosamine-3-sulfatase activity?
The first characterized gene is from Flavobacterium heparinum, encoding a 3-O-sulphatase. Human homologs may include sulfatases like SULF1 and SULF2, though direct evidence is limited.
What is the GO ID for N-sulfoglucosamine-3-sulfatase activity?
The Gene Ontology ID is GO:0033889.
Which organism was the enzyme first identified in?
Flavobacterium heparinum, a soil bacterium capable of degrading heparin.
What is the substrate of N-sulfoglucosamine-3-sulfatase?
The substrate is N-sulfo-D-glucosamine 3-O-sulfate units within heparin.
What is the product of the reaction?
The product is N-sulfo-D-glucosamine with the 3-sulfate group removed, releasing sulfate.
How can I study N-sulfoglucosamine-3-sulfatase activity in the lab?
You can use enzymatic activity assays, glycosaminoglycan analysis, and CRISPR-based gene editing to modulate the enzyme.
Is N-sulfoglucosamine-3-sulfatase activity involved in human disease?
No direct link has been established, but related sulfatase deficiencies cause mucopolysaccharidoses. Further research is needed.
What are the synonyms for N-sulfoglucosamine-3-sulfatase activity?
Synonyms include chondroitinsulfatase activity and N-sulfo-3-sulfoglucosamine 3-sulfohydrolase activity.
Can CRISPR be used to study this activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the gene's function.
Conclusion
N-sulfoglucosamine-3-sulfatase activity (GO:0033889) is a specialized enzymatic function involved in heparin and heparan sulfate degradation. Although first characterized in bacteria, its study has implications for glycosaminoglycan biology, drug development, and microbial pathogenesis. CRISPR-based tools now enable precise genetic manipulation to explore its roles in health and disease. Continued research will likely uncover new insights into sulfatase mechanisms and their therapeutic potential.
References
- 1. Bruce JS et al.. 1985. Flavobacterium heparinum 3-O-sulphatase for N-substituted glucosamine 3-O-sulphate.. Eur J Biochem 148(2):359-65 PMID: 3987694
